Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

New law broadens FDA safety authority, renews user fees

Article Abstract:

The new Food and Drug Administration Amendments Act (FDAAA) was signed into law in September 2007, thereby bringing relief to the biotechnology industry. The act is expected to put new emphasis on drug safety monitoring, hire additional staff for post-market surveillance and modernize its information technology systems.

Author: Fox, Jeffrey L.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Legal issues & crime, Government regulation, Legal/Government Regulation, Laws, regulations and rules, Biotechnology industry, Biotechnology industries, United States. Food and Drug Administration, Drug approval

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Blood products part of FDA xenotransplant plan

Article Abstract:

The US Food and Drug Administration (FDA) recently announced an extensive plan for regulating xenotransplant products and procedures. The agency also sought expert advice on establishing principles for easing those restrictions when xenotransplantation progresses from the mainly experimental stage to being widely used.

Author: Fox, Jeffrey L.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
DNA Clones

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


US bioethics committee weighs in

Article Abstract:

The report from the President's council on bioethics provides a precautionary analysis of prospects for using biotechnology to enhance personal health and performance. Two major federal reports, one on bioethics and the other on commercial developments and opportunities are presented.

Author: Fox, Jeffrey L.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
Management dynamics, Molecular Biological Products, Analysis, Management, Reports, Medical policy, Health policy, Company business management, Biotechnology, Bioethics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States
Similar abstracts:
  • Abstracts: Project management systems are right for treasury use. Training moves in-house with computer-assisted instruction
  • Abstracts: Cash flow statements - what are the choices? The reporting of companies' cash flows could lead to more comparable information
  • Abstracts: Building societies: no longer safe as houses? The lessons of thrift: learning the hard way. Doubtful recovery that's still in doubt
  • Abstracts: Metrocard vending machine. Williams-Sonoma web site. Play: Doors of Perception
  • Abstracts: Forget Goldilocks: bearish stories need to be taken seriously. Can history predict the future?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.